Abingworth as of March 31, 2017
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Crispr Therapeutics (CRSP) | 42.2 | $57M | 2.6M | 21.77 | |
Paratek Pharmaceuticals | 18.7 | $25M | 1.3M | 19.25 | |
Sientra | 13.8 | $18M | 2.2M | 8.39 | |
Cymabay Therapeutics | 5.1 | $6.9M | 1.6M | 4.29 | |
Cascadian Therapeutics | 2.9 | $3.8M | 925k | 4.14 | |
Chiasma | 2.6 | $3.5M | 2.1M | 1.70 | |
Proteon Therapeutics | 2.6 | $3.4M | 2.0M | 1.70 | |
Lombard Med (EVARF) | 2.0 | $2.7M | 3.5M | 0.78 | |
Cellectis S A (CLLS) | 1.8 | $2.4M | 100k | 24.00 | |
Dermira | 1.8 | $2.4M | 70k | 34.09 | |
Immune Design | 1.8 | $2.4M | 352k | 6.75 | |
Aurinia Pharmaceuticals (AUPH) | 1.4 | $1.8M | 252k | 7.33 | |
Histogenics Corp Cmn | 1.1 | $1.5M | 889k | 1.66 | |
Adaptimmune Therapeutics (ADAP) | 1.0 | $1.4M | 250k | 5.50 | |
Senseonics Hldgs (SENS) | 0.7 | $920k | 517k | 1.78 | |
Innocoll | 0.4 | $586k | 537k | 1.09 | |
Novan | 0.2 | $337k | 53k | 6.31 |